AstraZeneca announced a deal with the U.S. government to lower drug prices for American patients last Friday. According to the press release, AstraZeneca agreed “to a range of measures which will enable American patients to access medicines at prices that are equalized with those available in wealthy countries.” Under the agreement, AstraZeneca will provide Direct-to-Consumer (DTC)…
Pfizer stock jumps 14% as TrumpRx drug pricing deal eases tariff fears
Pfizer reached a voluntary agreement with the Trump administration on September 30, 2025, to cut prescription drug costs for American patients by matching prices in other developed countries and offering discounts up to 85% via a forthcoming federal platform, TrumpRx.gov, while committing $70 billion to U.S.-based R&D and manufacturing in exchange for a three-year tariff…